| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.21 | 3e-06 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.24 | 3e-06 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-06 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.25 | 5e-06 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.16 | 7e-06 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.14 | 8e-06 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.14 | 9e-06 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.14 | 9e-06 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.21 | 1e-05 |